Conservative Site-specific Recombination and Phase Variation
Targeted Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Timothy S Mulligan1, Jeff S Mumm2
1Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.
A new nitroreductase (NTR) variant, NTR 2.0, enables precise cell ablation in zebrafish. This improved system allows targeted cell elimination at lower drug doses, aiding regeneration studies and disease modeling.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: